Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer.

Small cell lung cancer (SCLC) exhibits insulin-like growth factor-dependent growth. SCLC is the most aggressive among known in vivo lung cancers, whereas in vitro growth of SCLC is paradoxically slow as compared with that of non-SCLC (NSCLC). In this study, we demonstrate that SCLC cells overexpress insulin-like growth factor binding protein (IGFBP)-2 via NeuroD, a neuroendocrine cell-specific transcription factor. Chromatin immunoprecipitation, electrophoretic mobility shift, and IGFBP-2 promoter assays all revealed that NeuroD binds to the E-box in the 5'-untranslated region of IGFBP-2. A NeuroD transgene in both airway epithelial and NSCLC cells up-regulated the transcription of IGFBP-2 and retarded cell growth. Recombinant IGFBP-2 repressed the growth of both airway epithelial and NSCLC cells in a dose-dependent manner. A NeuroD-specific small interfering RNA repressed IGFBP-2 expression in SCLC, and neutralization of IGFBP-2 and an IGFBP-2-specific small interfering RNA increased SCLC cell growth. Pathological samples of SCLC also expressed IGFBP-2 abundantly, as compared with NSCLC, and showed only rare (8%) IGFBP-2 promoter methylation, whereas the IGFBP-2 promoter was methylated in 71% of adenocarcinomas and 29% of squamous cell carcinomas. These findings suggest that 1) SCLC has an IGFBP-2 overexpression mechanism distinct from NSCLC, 2) secreted IGFBP-2 contributes to the slow growth of SCLC in vitro, and 3) the epigenetic alterations in the IGFBP-2 promoter contribute to the striking differences in IGFBP-2 expression between SCLC and NSCLC in vivo.

[1]  H. Dietz,et al.  Targeted Disruption of NeuroD, a Proneural Basic Helix-Loop-Helix Factor, Impairs Distal Lung Formation and Neuroendocrine Morphology in the Neonatal Lung , 2008, Journal of Biological Chemistry.

[2]  Shuta Tomida,et al.  Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. , 2008, Cancer research.

[3]  E. Brambilla.  Small Cell Carcinoma , 2008 .

[4]  R. Autorino,et al.  NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension? , 2007, European urology.

[5]  S. Nakano,et al.  Silencing of Insulin-like Growth Factor-binding Protein-2 in Human Glioblastoma Cells Reduces Both Invasiveness and Expression of Progression-associated Gene CD24* , 2007, Journal of Biological Chemistry.

[6]  P. Postmus,et al.  Basic Helix-Loop-Helix Transcription Factor Profiling of Lung Tumors Shows Aberrant Expression of the Proneural Gene Atonal Homolog 1 (ATOH1, HATH1, MATH1) in Neuroendocrine Tumors , 2007, The International journal of biological markers.

[7]  K. Hamada,et al.  Growth regulation via insulin-like growth factor binding protein-4 and -2 in association with mutant K-ras in lung epithelia. , 2006, The American journal of pathology.

[8]  Takehiko Fujisawa,et al.  Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis , 2006, Modern Pathology.

[9]  A. Hoeflich,et al.  Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. , 2005, Endocrinology.

[10]  Elisabeth Brambilla,et al.  Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .

[11]  F. Boyle,et al.  Elevated Serum Insulin-Like Growth Factor Binding Protein-2 as a Prognostic Marker in Patients with Ovarian Cancer , 2004, Clinical Cancer Research.

[12]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[13]  Takaaki Ito,et al.  Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma. , 2002, The American journal of pathology.

[14]  François Guillemot,et al.  Proneural genes and the specification of neural cell types , 2002, Nature Reviews Neuroscience.

[15]  B. Westerman,et al.  Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[17]  J. Minna,et al.  Molecular genetics of small cell lung carcinoma. , 2001, Seminars in oncology.

[18]  E. Huang,et al.  NeuroD-null mice are deaf due to a severe loss of the inner ear sensory neurons during development. , 2001, Development.

[19]  M. Tsai,et al.  BETA2 and pancreatic islet development. , 2001, Recent progress in hormone research.

[20]  O. Kallioniemi,et al.  Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. , 2000, Cancer research.

[21]  R. Kageyama,et al.  Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium. , 2000, Development.

[22]  V. Hwa,et al.  The Insulin-like Growth Factor-binding Protein (igfbp) Superfamily* , 2022 .

[23]  W. Yung,et al.  Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. , 1999, Cancer research.

[24]  T. Miyata,et al.  NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. , 1999, Genes & development.

[25]  Christopher Haslett,et al.  Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo , 1999, Nature Medicine.

[26]  H. Satoh,et al.  Lack of class II transactivator causes severe deficiency of HLA‐DR expression in small cell lung cancer , 1999, The Journal of pathology.

[27]  C. Cepko,et al.  NeuroD regulates multiple functions in the developing neural retina in rodent. , 1999, Development.

[28]  R. Kageyama,et al.  Helix-loop-helix factors in growth and differentiation of the vertebrate nervous system. , 1997, Current opinion in genetics & development.

[29]  M. Tsai,et al.  Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. , 1997, Genes & development.

[30]  J. Olson,et al.  Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors. , 1997, Cancer research.

[31]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[32]  S. Baylin,et al.  An achaete-scute homologue essential for neuroendocrine differentiation in the lung , 1997, Nature.

[33]  M. Tsai,et al.  The basic helix-loop-helix transcription factor BETA2/NeuroD is expressed in mammalian enteroendocrine cells and activates secretin gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Baxter,et al.  Insulin‐like growth factor‐binding protein‐2 in patients with prostate carcinoma and benign prostatic hyperplasia , 1997, Clinical endocrinology.

[35]  M. Binoux,et al.  Role of Insulin-Like Growth Factor Binding Protein-2 and Its Limited Proteolysis in Neuroblastoma Cell Proliferation: Modulation by Transforming Growth Factor-β and Retinoic Acid. , 1997, Endocrinology.

[36]  J. Ritter.  Tumors of the Lower Respiratory Tract: Atlas of Tumor Pathology , 1996 .

[37]  H. Weintraub,et al.  Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. , 1995, Science.

[38]  M. Tsai,et al.  Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. , 1995, Genes & development.

[39]  F. Garrouste,et al.  Alterations in serum levels of insulin‐like growth factors and insulin‐like growth‐factor‐binding proteins in patients with colorectal cancer , 1994, International journal of cancer.

[40]  N. Bleehen,et al.  Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. , 1993, Cancer research.

[41]  S. Baylin,et al.  Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  N. Bleehen,et al.  Expression of insulinlike growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines. , 1992, Journal of the National Cancer Institute.

[43]  David J. Anderson,et al.  Two rat homologues of Drosophila achaete-scute specifically expressed in neuronal precursors , 1990, Nature.

[44]  I. Smith,et al.  Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells. , 1990, Cancer research.

[45]  R. Ginsberg,et al.  Staging and prognostic factors in small cell lung cancer: a consensus report , 1989 .

[46]  G. Jaques,et al.  Production of insulin-like growth factor binding proteins by small-cell lung cancer cell lines. , 1989, Experimental cell research.

[47]  J. Minna,et al.  Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. , 1988, The Journal of clinical investigation.

[48]  J. Minna,et al.  Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. , 1985, Cancer research.

[49]  G. Bepler,et al.  Establishment and identification of small cell lung cancer cell lines having classic and variant features. , 1985, Cancer research.

[50]  I A Mjör,et al.  Consensus Report , 1985, Journal of dental research.

[51]  John D. Minna,et al.  Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer , 1985, Nature.

[52]  D. Ettinger,et al.  Staging and prognostic factors in small cell carcinoma of the lung. , 1983, Cancer treatment reports.

[53]  Harlan I. Firminger,et al.  Atlas of tumor pathology , 1954 .

[54]  A. Liebow.  Tumors of the lower respiratory tract , 1952 .